Immune system response in pancreatic cancers is sparked by immunotherapy, antibodies, and pancreatic cancer vaccine.

Published Date: 19 Jul 2023

delivering a three-pronged immunotherapy regimen to patients with operable pancreatic cancers that combines the pancreatic cancer vaccine GVAX with the immune checkpoint medication nivolumab and the anti-CD137 agonist urelemab.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Aspirin Fails to Boost Survival in Colorectal Cancer Trial

2.

Do Anatomy Atlases Reflect Social Inequalities?

3.

A higher risk of chemotherapy-induced peripheral neuropathy is associated with a deficiency in vitamin D prior to treatment.

4.

Some triple negative breast cancers might be avoided by longer breastfeeding

5.

Quizartinib Benefit in AML Limited to FLT3-Mutated Subgroup


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot